ELI LILLY & Co
SEC insider (Form 3/4/5 filer). CIK 0000059478. 10% Owner at Lycia Therapeutics, Inc. (LYCA) and 3 other issuers. 4 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in INDIANAPOLIS, IN.
Companies ELI LILLY & Co has filed insider reports for
- Lycia Therapeutics, Inc. (LYCA): 10% Owner
- TRex Bio, Inc. (TRXB): 10% Owner
- Scribe Therapeutics, Inc. (SCTX): 10% Owner
- Aktis Oncology, Inc. (AKTS): 10% Owner
ELI LILLY & Co
CIK: 0000059478
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
4 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 4 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions